Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma.

Sewanti LimayeDarshana PatilDadasaheb AkolkarNavin SrivastavaRevati PatilSachin ApurwaSanket PatilJinumary JohnRahul GosaviPrabhu NesargikarPrashant KumarVineet DattaChirantan BoseZarrine RaaziAjay SrinivasanRajan Datar

Published in: Clinical case reports (2021)

Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely and effectively used in combination with cytotoxic anti-cancer agents for treatment of Gastric cancers.

Keyphrases

endothelial cells
squamous cell carcinoma
vascular endothelial growth factor
radiation therapy
locally advanced